4 aspects of a fast-tracked COVID-19 vaccine that may complicate promotion
A rushed coronavirus vaccine could be a messaging minefield for medical marketers attempting to convince a wary public.
-
-
A snapshot of social COVID-19 conversations found bots, anti-vaxxers and concerns about medication access
CMI/Compas releases a weekly COVID-19 social listening report. -
The MM&M Podcast 6.3.2020: 2020 Agency 100 Preview
MM&M’s Steve Madden, Marc Iskowitz, Sean Ayling and Larry Dobrow serve up a preview of this year’s Agency 100 report, including the big cover reveal, a look at agency-world trends and a glance ahead at a potential post-COVID landscape. -
An updated guide to how pharma and agencies are reacting to George Floyd’s death
This list will be updated regularly as industry responds to the killing of Floyd and other black victims of police brutality. -
Watch: Short film shows what happens when healthcare loses its humanity
The film, Instant Doctor, was created by The Bloc and The Youth for digital platform Tribute.
LATEST NEWS
The Escalator: Healthcasts Media appoints sales, operations head
Plus people moves at Moon Rabbit and Moderna.
Five things for pharma marketers to know: Friday, June 5, 2020
Hydroxychloroquine study suggesting safety risks retracted; Health official urges protesters to get tested for COVID-19; AstraZeneca to distribute 2 billion doses of potential coronavirus vaccine.
Companies step up philanthropy, research efforts to battle COVID-19
The COVID-19 pandemic has brought out the best in the healthcare marketing industry. Here’s a roundup of what various companies are doing.
Coronavirus Briefing: Protest-related spikes, brand pivots and the unfolding eldercare tragedy
This week’s Coronavirus Briefing is 979 words and will take you five minutes to read.
‘As a company there is more that we must do internally and we will,’ says McCann WorldGroup CEO to staff
The network – following its IPG parent company’s footsteps – is closing all offices on June 5.
Five things for pharma marketers to know: Thursday, June 4, 2020
Hydroxychloroquine study finds it does not prevent COVID-19 in exposed patients; Federal government picks five promising coronavirus vaccines; Gilead could earn $7 in revenue from remdesivir.
Five things for pharma marketers to know: Wednesday, June 3, 2020
Gilead develops easier-to-administer versions of Remdesivir; Pharma, agencies respond to George Floyd’s death; Social distancing most effective way to combat COVID-19.
Arthur Sadoun ‘extremely worried for the world’ as civil unrest continues in US
Publicis CEO also called for industry-wide solidarity in light of COVID-19.
Havas CEO tells staff to take day and ‘contemplate our roles in improving racial justice and diversity’
Yannick Bolloré acknowledges ‘America is in pain right now’ amid the George Floyd outcry.
Five things for pharma marketers to know: Tuesday, June 2, 2020
26,000 nursing home residents died from COVID-19; Remdesivir modestly improves condition for some patients; Register for the MM&M Agency 100.
